Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression

被引:11
作者
Deng, Gang [1 ]
Wang, Fei [2 ]
Song, YiSa [2 ]
机构
[1] Wuhan 1 Hosp Hubei Prov, Dept Otorhinolaryngol, Wuhan, Hubei, Peoples R China
[2] Peoples Hosp Qinghai Prov, Dept Otorhinolaryngol, Xining, Qinghai, Peoples R China
关键词
CircSETD3; microRNA-147a; nasopharyngeal carcinoma; cisplatin resistance; CELL LUNG-CANCER; PROGRESSION; ACTS;
D O I
10.1080/21655979.2022.2036907
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Circular RNA (circRNA) plays a crucial role in the establishment and progression of nasopharyngeal carcinoma (NPC). Understanding the role of circRNA in NPC is helpful to find new therapeutic targets for NPC. The purpose of this study was to explore the effects of circRNA SET domain protein 3 (circSETD3) on protein kinase B (Akt)/ mammalian target of rapamycin (mTOR) signaling pathway and cisplatin (DDP) resistance to NPC and explore its downstream mechanism. The results showed that circSETD3 was upregulated in NPC tissues and was related to DDP resistance to NPC. Functional experiments revealed that circSETD3 knockdown inhibited NPC proliferation and increased DDP sensitivity and apoptosis rate. The promotion effect of circSETD3 overexpression on NPC proliferation and DDP resistance and inhibition effect on apoptosis was reversed by elevated miR-147a. CircSETD3 knockdown or miR-147a overexpression prevented Akt/mTOR pathway's activation. In terms of the mechanism, circSETD3 acted as a sponge for miR-147a. Xenotransplantation experiments showed that knockdown circSETD3 or DDP treatment could restrain tumor growth, and the effect of DDP was enhanced by knockdown of circSETD3. In conclusion, the results of this study confirm that circSETD3 promotes NPC proliferation and DDP resistance by regulating miR-147a, and circSETD3/miR-147a axis may serve as a potential therapeutic target for NPC in the future.
引用
收藏
页码:5843 / 5854
页数:12
相关论文
共 34 条
[11]   HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness [J].
Ho, Jessica S. Y. ;
Di Tullio, Federico ;
Schwarz, Megan ;
Low, Diana ;
Incarnato, Danny ;
Gay, Florence ;
Tabaglio, Tommaso ;
Zhang, JingXian ;
Wollmann, Heike ;
Chen, Leilei ;
An, Omer ;
Chan, Tim Hon Man ;
Hickman, Alexander Hall ;
Zheng, Simin ;
Roudko, Vladimir ;
Chen, Sujun ;
Karz, Alcida ;
Ahmed, Musaddeque ;
He, Housheng Hansen ;
Greenbaum, Benjamin D. ;
Oliviero, Salvatore ;
Serresi, Michela ;
Gargiulo, Gaetano ;
Mann, Karen M. ;
Hernando, Eva ;
Mulholland, David ;
Marazzi, Ivan ;
Wee, Dave Keng Boon ;
Guccione, Ernesto .
ELIFE, 2021, 10
[12]   Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1 [J].
Hong, Xiaohong ;
Liu, Na ;
Liang, Yelin ;
He, Qingmei ;
Yang, Xiaojing ;
Lei, Yuan ;
Zhang, Panpan ;
Zhao, Yin ;
He, Shiwei ;
Wang, Yaqin ;
Li, Junyan ;
Li, Qian ;
Ma, Jun ;
Li, Yingqin .
MOLECULAR CANCER, 2020, 19 (01)
[13]   RETRACTED: Antagonist targeting miR-106b-5p attenuates acute renal injury by regulating renal function, apoptosis and autophagy via the upregulation of TCF4 (Retracted Article) [J].
Hu, Jing-Meng ;
He, Li-Jie ;
Wang, Peng-Bo ;
Yu, Yan ;
Ye, Ya-Ping ;
Liang, Li .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2021, 48 (03)
[14]   Plac8-mediated autophagy regulates nasopharyngeal carcinoma cell function via AKT/mTOR pathway [J].
Huang, Mao-Ling ;
Qi, Cheng-Lin ;
Zou, You ;
Yang, Rui ;
Jiang, Yang ;
Sheng, Jian-Fei ;
Kong, Yong-Gang ;
Tao, Ze-Zhang ;
Chen, Shi-Ming .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (14) :7778-7788
[15]   circSETD3 Contributes to Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer by Targeting the miR-520h/ABCG2 Pathway [J].
Huang, Yutang ;
Dai, Yi ;
Wen, Chunjie ;
He, Shuai ;
Shi, Jingjing ;
Zhao, Dezhang ;
Wu, Lanxiang ;
Zhou, Honghao .
MOLECULAR THERAPY NUCLEIC ACIDS, 2020, 21 :885-899
[16]   NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma [J].
Lee, Anne W. M. ;
Ngan, Roger K. C. ;
Ng, Wai-Tong ;
Tung, Stewart Y. ;
Cheng, Ashley A. C. ;
Kwong, Dora L. W. ;
Lu, Tai-Xiang ;
Chan, Anthony T. C. ;
Sze, Henry C. K. ;
Yiu, Harry H. Y. ;
Wong, Frank C. S. ;
Yuen, Kam-Tong ;
Chappell, Rick ;
Choi, Horace C. W. .
CANCER, 2020, 126 (16) :3674-3688
[17]   Long Non-coding RNA LINC00847 Induced by E2F1 Accelerates Non-small Cell Lung Cancer Progression Through Targeting miR-147a/IFITM1 Axis [J].
Li, Huan ;
Chen, Yao-kai ;
Wan, Qiu ;
Shi, An-qi ;
Wang, Min ;
He, Ping ;
Tang, Li-xin .
FRONTIERS IN MEDICINE, 2021, 8
[18]   Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107 [J].
Li, Wanpeng ;
Lu, Hanyu ;
Wang, Huan ;
Ning, Xianhui ;
Liu, Quan ;
Zhang, Huankang ;
Liu, Zhuofu ;
Wang, Jingjing ;
Zhao, Weidong ;
Gu, Yurong ;
Li, Houyong ;
Sun, Xicai ;
Hu, Li ;
Wang, Dehui .
CANCER LETTERS, 2021, 499 :301-313
[19]   Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met [J].
Lin, Feng-Jie ;
Lin, Xian-Dong ;
Xu, Lu-Ying ;
Zhu, Shi-Quan .
MOLECULES AND CELLS, 2020, 43 (10) :856-869
[20]   miR-147a suppresses the metastasis of non-small-cell lung cancer by targeting CCL5 [J].
Lu, Yan ;
Luan, Xiao Rong .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019,